Results 201 to 210 of about 326,147 (312)

PD‐1/PD‐L1 in Hepatocellular Carcinoma (2014–2024): A Combined Macro and Micro Analysis of Immunotherapy Implications

iNew Medicine, EarlyView.
ABSTRACT Hepatocellular carcinoma (HCC) represents a significant global health issue, with the PD‐1/PD‐L1 axis serving a pivotal target for immunotherapy in this malignancy. However, a comprehensive bibliometric analysis of PD‐1/PD‐L1 research in HCC is lacking.
Xingyu Zhu, Lin Tang, Hongyan Li, Hao Li, Jiamei Wang   +4 more
wiley   +1 more source

Genetic Variants in Liver Cirrhosis: Classifications, Mechanisms, and Implications for Clinical Practice. [PDF]

J Pers Med
Raghavan RP, Alexander KT, Sadasivan S, Parmar C, Kathirvel M.   +4 more
europepmc   +1 more source

Bariatric surgery’s impact on hepatic cirrhosis: a therapeutic bridge in advanced liver disease

Yong Sup Lee, Pavlos Jonthan, W. T. Chen, Catharina Grulich   +3 more
openalex   +1 more source

Beyond a Conduit: The Evolution of Functional Biliary Stents From Active Intervention to Enabling Platforms

iNew Medicine, EarlyView.
This review traces the evolution of functional biliary stents, outlining the paradigm shift from “active intervention” strategies that target stent failure to next‐generation “enabling platforms.” These platforms leverage biodegradable materials, 3D/4D printing, and smart sensors to achieve personalized, regenerative, and theranostic solutions ...
Muhan Li, Xu Liu, Xin Ye, Zhixia Dong, Xinjian Wan   +4 more
wiley   +1 more source

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Refractory Cirrhotic Ascites and Diabetes: Scoping Review Protocol.

JMIR Res Protoc
Laeeq T, Kamal AM, Kasi ABU, Shabbar Banatwala UES, Baloch A, Sagaribay R, Goel V, Singh A, Batra K.   +8 more
europepmc   +1 more source

ROTEM-detected hypocoagulability is associated with major non-portal hypertensive bleeding in cirrhosis. [PDF]

Hepatol Commun
Ferdinande K, Decaestecker J, De Vloo C, Raevens S, Seynhaeve L, Dewyspelaere J, Degroote H, van Haute I, Geerts A, Verhelst X, Van Vlierberghe H, Devreese KMJ.   +11 more
europepmc   +1 more source

A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis: Editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis” [PDF]

Jing Zeng, Jian-Gao Fan
openalex   +1 more source

Virtual Magnetic Resonance Elastography Using a Deep Generative Model for Liver Fibrosis Staging

iRADIOLOGY, EarlyView.
The proposed Registration‐based Generative Adversarial Network‐Convolutional Block Attention Module (RegGAN‐CBAM) model efficiently and reliably generates virtual MR elastography using diffusion weighted imaging. Strong correlation between virtual and native MR elastography for liver stiffness and viscosity are observed.
Longyu Sun, Yikun Wang, Yan Li, Xumei Hu, Wenyue Mao, Mengting Sun, Zian Wang, Fuhua Yan, Ruokun Li, Chengyan Wang   +9 more
wiley   +1 more source

Sleep patterns, genetic factors and the risk of cirrhosis: a prospective cohort study. [PDF]

Hum Genomics
Lin F, Zhang H, Xu H, Cheng L, Guo W, Wang M, Yu C.   +6 more
europepmc   +1 more source

A Comparative Study of Ultrasonography and CT Venography in the Diagnosis of Budd‐Chiari Syndrome

Journal of Clinical Ultrasound, EarlyView.
Budd‐Chiari syndrome (BCS) is characterized by hepatic venous outflow obstruction from the hepatic veins to the junction of the inferior vena cava (IVC) and right atrium. Ultrasound (US) and CT venography (CTV) are used as imaging techniques for the diagnosis of BCS, and We compared the diagnostic efficacy of the two modalities. The results showed that
Tiling Jiang, Mingyue Qu, Qian Zhang, Donghua Shen, Yan Liu, Baoshi Guo, Gong Wang   +6 more
wiley   +1 more source